Moreover, total cholesterol (TC) metabolism is significantly altered in NAFLD patients, as reflected by both increased cholesterol synthesis and diminished absorption (9), and excessive cholesterol build-up leads to pancreatic β-cell dysfunction, disrupts glucose tolerance, and affects insulin secretion. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.